CABG Clinical Trial
Official title:
Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass Surgery
This research is being done to see if giving a hormone called GLP-1 can improve heart function and reduce length of stay in the Cardiac Surgical Intensive Care Unit (CSICU) in people who have non-emergent coronary artery bypass graft (CABG) surgery.
After CABG surgery, a condition known as hyperglycemia or high blood sugar often occurs even
in patients who have never been diagnosed with diabetes. This high blood sugar can lead to
complications after surgery such as infections at the site of the incision. Additionally, if
there is any cardiac muscle injury either prior to or during surgery, the injured cardiac
muscle can not use glucose (the body's fuel and energy source) as well as it did prior to
the injury. This reduced ability to use glucose slows the cardiac muscles ability to repair
itself and provide the normal pumping force and function needed to circulate the blood
throughout the body. This inability to repair itself and/or provide the normal pumping force
and function can make it difficult for the patient as well as increase the length of stay
required in the CSICU.
GLP-1 has the ability to lower blood sugar and help cells use glucose for fuel and energy
but when the blood sugar becomes low its glucose lowering ability decreases. In this study,
we want to see we want to see if GLP-1 may help keep the blood sugar within normal limits
and reduce or eliminate the need for insulin. We will also see whether it will help the
heart recover more quickly.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01928745 -
Experimental Determination of Atot en Ka in the Critically Ill
|
N/A | |
| Completed |
NCT01956708 -
Transfer of Cardioprotection During RIPC
|
N/A | |
| Completed |
NCT00524901 -
Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia
|
Phase 2 | |
| Completed |
NCT01282671 -
Effects of Deep Breathing Exercises Two Months After Cardiac Surgery
|
Phase 2 | |
| Completed |
NCT03050489 -
Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG
|
||
| Recruiting |
NCT06124937 -
Empagliflozin to Prevent Post-Operative Atrial Fibrillation
|
Phase 3 | |
| Completed |
NCT00269243 -
Management With Accupril Post Bypass Graft
|
Phase 4 | |
| Recruiting |
NCT03139929 -
Measurement of MSFP and Stressed Volume With CardioQ+®
|
||
| Active, not recruiting |
NCT03424941 -
The TransCatheter Valve and Vessels Trial
|
N/A | |
| Completed |
NCT06317363 -
Effects of Acapella VS CHEST Physiotherapy in Post-Operative CABG Patients
|
N/A | |
| Completed |
NCT05023083 -
Cross Cultural Adaptation of Functional Status Questionnaire in Urdu Language in CABG Patients
|
||
| Completed |
NCT03800264 -
Bisoprolol Versus Corticosteroid and Bisoprolol Combination for Prophylaxis Against Atrial Fibrillation After on Pump Coronary Artery Bypass Surgery
|
Phase 4 | |
| Completed |
NCT05285865 -
Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients
|
N/A | |
| Not yet recruiting |
NCT06173609 -
Long LIMA Patch on Left Anterior Descending Coronary Artery in CABG
|
||
| Not yet recruiting |
NCT06238011 -
Dexmedetomidine vs Control on Attenuation Hemodynamic Response to Noxious Stimuli in CABG Surgical Patients
|
N/A | |
| Active, not recruiting |
NCT06127147 -
High-intensity Inspiratory Muscle Training as a Pre-cardiac Rehabilitation in Heart Disease
|
N/A | |
| Recruiting |
NCT06029556 -
Effects of Early Mobility Protocols in Cardiac ICU
|
N/A | |
| Enrolling by invitation |
NCT01205620 -
IRB-HSR# 15084 A Prospective, Unblinded, Controlled Study to Evaluate the Effect of the ITPR in Patients Undergoing OPCAB Surgery
|
Phase 2 |